Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

4.0%

2 terminated/withdrawn out of 50 trials

Success Rate

93.1%

+6.6% vs industry average

Late-Stage Pipeline

12%

6 trials in Phase 3/4

Results Transparency

22%

6 of 27 completed trials have results

Key Signals

9 recruiting6 with results

Enrollment Performance

Analytics

N/A

16(43.2%)

Phase 2

8(21.6%)

Phase 1

5(13.5%)

Phase 4

4(10.8%)

Early Phase 1

2(5.4%)

Phase 3

2(5.4%)

37Total

N/A(16)

Phase 2(8)

Phase 1(5)

Phase 4(4)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (50)

Showing 20 of 50 trials

NCT03648918Recruiting

Genetics Of Autoimmunity In Type I Diabetes

Role: collaborator

NCT06401577Recruiting

Diabetes RElated to Acute Pancreatitis and Its Mechanisms: Metabolic Outcomes Using Novel CGM Metrics

Role: collaborator

NCT07377929Recruiting

Intradetrusor Onabotulinumtoxin A (Botox) at the Time of Transurethral Resection of the Prostate or Transurethral Waterjet Ablation of the Prostate for Mixed Lower Urinary Tract Symptoms

Role: lead

NCT03369821Recruiting

EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)

Role: collaborator

NCT05197920Recruiting

Diabetes RElated to Acute Pancreatitis and Its Mechanisms

Role: collaborator

NCT05878236Recruiting

iMmune SignAtures and Clinical outComes in AP

Role: collaborator

NCT06585540Phase 3Recruiting

A Pilot Study to Evaluate Barhemsys for the Prevention of Postoperative Nausea and Vomiting in the Bariatric Surgery Population

Role: lead

NCT06453993Not ApplicableCompleted

Temporal Variation in Exhaled Volatile Organic Compounds in Esophageal Cancer Patients

Role: lead

NCT06265376Not ApplicableCompleted

Do Patient Educational Videos Improve Pain and Recovery After Laparoscopic Hysterectomy?

Role: lead

NCT06531655Withdrawn

Intradetrusor Botox at the Time of Transurethral Resection of the Prostate for Mixed Lower Urinary Tract Symptoms

Role: lead

NCT04754737Not ApplicableRecruiting

Antibiotic Usage Prior to OnabotulinumtoxinA Injection

Role: lead

NCT06314516Completed

Influence of Nutrition and Sarcopenia on Esophageal Cancer Outcomes

Role: lead

NCT05281614Early Phase 1Completed

Immune Effects of Vedolizumab With or Without Anti-TNF Pre-treatment in T1D

Role: lead

NCT03423862Completed

Development of Predictive Biomarkers

Role: collaborator

NCT04933084Not ApplicableUnknown

Pre-operative Education Modalities to Decrease Opioid Use

Role: lead

NCT05868993Phase 4Unknown

Optimal Effective Local Anesthetic Volume for Pain Relief Using Brachial Plexus Block

Role: lead

NCT05847413Early Phase 1Completed

Targeting Beta Cell Dysfunction With Verapamil in Longstanding T1D

Role: lead

NCT04378777Completed

Immunophenotyping Assessment in a COVID-19 Cohort

Role: collaborator

NCT03703089Phase 1Unknown

Gemcitabine & Nab-Paclitaxel in Pancreatic Adenocarcinoma With Positive Peritoneal Cytology

Role: lead

NCT04821245Completed

Defining Normal Postoperative Magnetic Resonance Imaging After Total Knee Arthroplasty

Role: lead